AWM
ROIV icon

Activest Wealth Management’s Roivant Sciences ROIV Stock Holding History

Activest Wealth Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106 Sell
3
-46
-94% -$1.36K ﹤0.01% 1233
2026
Q1 		$1.36K Buy
49
+1
+2% +$26 ﹤0.01% 996
2025
Q4 		$1.04K Hold
48
– – ﹤0.01% 943
2025
Q3 		$726 Buy
48
+2
+4% +$25 ﹤0.01% 915
2025
Q2 		$518 Buy
+46
New +$499 ﹤0.01% 860
2025
Q1 		– Sell
-1
Closed -$11 – 1155
2024
Q4 		$12 Buy
+1
New +$12 ﹤0.01% 874

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Activest Wealth Management's ROIV Position: Q2 2026 in Review

Activest Wealth Management reduced its Roivant Sciences (ROIV) stake by 94% in Q2 2026, selling an estimated $1.36K and leaving 3 shares worth $106. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Activest Wealth Management first reported a position in ROIV in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.36K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Activest Wealth Management held 3 shares of Roivant Sciences worth $106 as of Q2 2026.
  • Activest Wealth Management sold 46 Roivant Sciences shares in Q2 2026, an estimated $1.36K.
  • Roivant Sciences made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1233 holding.
  • Activest Wealth Management first reported a position in Roivant Sciences in Q4 2024 and has held it in 6 quarters since.
  • Activest Wealth Management's Roivant Sciences position peaked at $1.36K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.